Search Results - "Collins, Sabrina" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm

Quantitative Systems Pharmacology Approaches for Immuno‐Oncology: Adding Virtual Patients to the Development Paradigm

by Chelliah, Vijayalakshmi, Lazarou, Georgia, Bhatnagar, Sumit, Gibbs, John P., Nijsen, Marjoleen, Ray, Avijit, Stoll, Brian, Thompson, R. Adam, Gulati, Abhishek, Soukharev, Serguei, Yamada, Akihiro, Weddell, Jared, Sayama, Hiroyuki, Oishi, Masayo, Wittemer‐Rump, Sabine, Patel, Chirag, Niederalt, Christoph, Burghaus, Rolf, Scheerans, Christian, Lippert, Jörg, Kabilan, Senthil, Kareva, Irina, Belousova, Natalya, Rolfe, Alex, Zutshi, Anup, Chenel, Marylore, Venezia, Filippo, Fouliard, Sylvain, Oberwittler, Heike, Scholer‐Dahirel, Alix, Lelievre, Helene, Bottino, Dean, Collins, Sabrina C., Nguyen, Hoa Q., Wang, Haiqing, Yoneyama, Tomoki, Zhu, Andy Z.X., Graaf, Piet H., Kierzek, Andrzej M.
Published in Clinical pharmacology and therapeutics (01.03.2021)

Get full text

Journal Article

Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor

Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor

by Coser, Kathryn R, Wittner, Ben S, Rosenthal, Noël F, Collins, Sabrina C, Melas, Antonia, Smith, Shannon L, Mahoney, Crystal J, Shioda, Keiko, Isselbacher, Kurt J, Ramaswamy, Sridhar, Shioda, Toshi
Published in Proceedings of the National Academy of Sciences - PNAS (25.08.2009)

Get full text

Journal Article

$357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma$

357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma

by Collins, Sabrina, Joshi, Adarsh, Shen, Lei, Das, Subhasree, Suryanarayan, Kaveri, Bottino, Dean, Li, Cheryl, Curley, Michael, Wang, Dannie, Abadier, Michael, Larson, Ryan, Parot, Xavier
Published in Journal for immunotherapy of cancer (01.11.2020)

Get full text

Journal Article

1068 Evaluation of the innate and adaptive immune modulatory properties and anti-tumor activity of CD38-targeted interferon alpha

1068 Evaluation of the innate and adaptive immune modulatory properties and anti-tumor activity of CD38-targeted interferon alpha

by Sampson, James F, Zhang, Hong, Hara, Tomoya, Zhang, Dong Mei, Hinthorne, Adam J, Collins, Sabrina C, Curley, Michael D
Published in Journal for immunotherapy of cancer (01.11.2023)

Get full text

Journal Article

Modakafusp Alfa (TAK-573), a Novel CD38-Targeting Attenuated Interferon-Alpha Immunocytokine, Kills MM Cells Via NK Cell Activation

Modakafusp Alfa (TAK-573), a Novel CD38-Targeting Attenuated Interferon-Alpha Immunocytokine, Kills MM Cells Via NK Cell Activation

by Bruins, Wassilis S.C., Rentenaar, Rosa, Collins, Sabrina, Sampson, James F., Van De Donk, Niels WCJ, Zweegman, Sonja, Mutis, Tuna
Published in Blood (15.11.2022)

Get full text

Journal Article

$Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)$

Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

by Vogl, Dan T., Atrash, Shebli, Holstein, Sarah A., Nadeem, Omar, Benson, Don M., Suryanarayan, Kaveri, Liu, Yuyin, Collins, Sabrina, Parot, Xavier, Kaufman, Jonathan L.
Published in Blood (15.11.2022)

Get full text

Journal Article

Effects on coping skills and anxiety of a universal school-based mental health intervention delivered in Scottish primary schools

Effects on coping skills and anxiety of a universal school-based mental health intervention delivered in Scottish primary schools

by Collins, Sabrina, Woolfson, Lisa Marks, Durkin, Kevin
Published in School psychology international (01.02.2014)

Get full text

Journal Article

Dose escalation of a phase 1b/2 study of modakafusp alfa, an immune-targeting attenuated cytokine, in patients (pts) with metastatic solid tumors

Dose escalation of a phase 1b/2 study of modakafusp alfa, an immune-targeting attenuated cytokine, in patients (pts) with metastatic solid tumors

by Johnson, Melissa Lynne, Abdul-Karim, Raghad, Sommerhalder, David, Hafez, Navid, Wang, Shining, Li, Cheryl, Liu, Yuyin, Yang, Lili, Collins, Sabrina, Parot, Xavier, Strauss, James F.
Published in Journal of clinical oncology (01.06.2022)

Get full text

Journal Article

$Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)$

Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

by Saggu, Gurpanna, Lee, Min Young, Dunbar, Faith, Singh, Reshma, Sachsenmeier, Kris, Vogl, Dan T., Atrash, Shebli, Holstein, Sarah A., Nadeem, Omar, Kaufman, Jonathan L., Joshi, Adarsh, Suryanarayan, Kaveri, Collins, Sabrina
Published in Blood (02.11.2023)

Get full text

Journal Article

Abstract 5546: A murine reactive version of TAK-573 (anti-CD38 attenuated IFNα fusion protein) shows immunomodulatory and antitumor activity, alone and in combination with standard-of-care agents, in IFNa-insensitive, immunocompetent murine multiple myeloma tumor models

Abstract 5546: A murine reactive version of TAK-573 (anti-CD38 attenuated IFNα fusion protein) shows immunomodulatory and antitumor activity, alone and in combination with standard-of-care agents, in IFNa-insensitive, immunocompetent murine multiple myeloma tumor models

by Hara, Tomoya, Wong, Christina, Yu, Jie, Collins, Sabrina, Wang, Haiqing, Sugimoto, Hiroshi, Zhang, Hong, Bjorck, Pia, Curley, Michael D.
Published in Cancer research (Chicago, Ill.) (15.08.2020)

Get full text

Journal Article

$Modakafusp Alfa (TAK-573), an Immunocytokine, Shows Clinical Activity in Patients with Relapsed/Refractory Multiple Myeloma; Updated Results from a First-in-Human Phase 1 Study$

Modakafusp Alfa (TAK-573), an Immunocytokine, Shows Clinical Activity in Patients with Relapsed/Refractory Multiple Myeloma; Updated Results from a First-in-Human Phase 1 Study

by Vogl, Dan T., Kaufman, Jonathan L., Holstein, Sarah A., Atrash, Shebli, Nadeem, Omar, Janakiram, Murali, Suryanarayan, Kaveri, Liu, Yuyin, Collins, Sabrina, Parot, Xavier, Chaudhry, Maria
Published in Blood (23.11.2021)

Get full text

Journal Article

$TAK-573, an Anti-CD38/Attenuated Ifnα Fusion Protein, Has Clinical Activity and Modulates the Ifnα Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma$

TAK-573, an Anti-CD38/Attenuated Ifnα Fusion Protein, Has Clinical Activity and Modulates the Ifnα Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma

by Vogl, Dan T., Kaufman, Jonathan L., Holstein, Sara A., Nadeem, Omar, O'Donnell, Elizabeth, Suryanarayan, Kaveri, Collins, Sabrina, Parot, Xavier, Chaudhry, Maria
Published in Blood (05.11.2020)

Get full text

Journal Article

Abstract CT065: Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors

Abstract CT065: Modakafusp alfa shows intratumoral immune pharmacodynamics (PD) in a subset of patients (pts) in a phase 1b study in advanced/metastatic solid tumors

by Saggu, Gurpanna, Markman, Janet L., Lee, Min Young, Dunbar, Faith, Joshi, Adarsh, Wang, Shining, Collins, Sabrina
Published in Cancer research (Chicago, Ill.) (05.04.2024)

Get full text

Journal Article

P-198 Immunomodulatory Effects of Daratumumab on the Bone Marrow Microenvironment in Multiple Myeloma: Insights from Single-Cell Analyses

P-198 Immunomodulatory Effects of Daratumumab on the Bone Marrow Microenvironment in Multiple Myeloma: Insights from Single-Cell Analyses

by Bekri, Selma, Damle, Gargi, Demircioglu, Deniz, Kats, Simone, Kelly, Geoffrey, Dawson, Travis, Darwin, D'souza, Collins, Sabrina, Kim-Schulze, Seunghee, Gnjatic, Sacha, Parekh, Samir, Jagannath, Sundar, Lagana, Alessandro, Cho, Hearn Jay
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)

Get full text

Journal Article

$a Phase 1b/2 Study of TAK-659, an Investigational Dual SYK and FLT-3 Inhibitor, in Patients (Pts) with Relapsed or Refractory Acute Myelogenous Leukemia (R/R AML)$

a Phase 1b/2 Study of TAK-659, an Investigational Dual SYK and FLT-3 Inhibitor, in Patients (Pts) with Relapsed or Refractory Acute Myelogenous Leukemia (R/R AML)

by Kaplan, Jason B, Bixby, Dale L., Morris, John C, Frankfurt, Olga, Altman, Jessica, Wise-Draper, Trisha, Burke, Patrick W., Collins, Sabrina, Kannan, Karuppiah, Wang, Ling, Faucette, Stephanie, Lee, Benjamin, Shou, Yaping, Levis, Mark J., Pratz, Keith W.
Published in Blood (02.12.2016)

Get full text

Journal Article

PUB140 A Pilot Study to Assess Circulating Tumor Cells, Circulating Tumor Cell DNA and Cell Free DNA in Patients with Small Cell Lung Cancer

PUB140 A Pilot Study to Assess Circulating Tumor Cells, Circulating Tumor Cell DNA and Cell Free DNA in Patients with Small Cell Lung Cancer

by Aggarwal, Charu, Badola, Sunita, Shin, Hyunjin, Bedford, Lisa, Collins, Sabrina, Derk, Blair, Fostel, Jen, Ecsedy, Jeffrey, Evans, Tracey, Bauml, Joshua, Cohen, Roger, Vachani, Anil, Langer, Corey, Niu, Huifeng
Published in Journal of thoracic oncology (01.01.2017)

Get full text

Journal Article

Abstract B213: Toward better preclinical combination studies: Using constrained optimization techniques in combination dosage and study design

Abstract B213: Toward better preclinical combination studies: Using constrained optimization techniques in combination dosage and study design

by Chen, Andrew, Collins, Sabrina, Mettetal, Jerome, Manfredi, Mark, Galvin, Katherine, Shyu, Wen Chyi, Ecsedy, Jeffrey, Palani, Santhosh, Chakravarty, Arijit
Published in Molecular cancer therapeutics (01.11.2013)

Get full text

Journal Article

Abstract 3738: A rationale for combining the targeted investigational agents TAK-733, a MEK1/2 inhibitor, with alisertib (MLN8237), an Aurora A kinase inhibitor, for cancer therapy

Abstract 3738: A rationale for combining the targeted investigational agents TAK-733, a MEK1/2 inhibitor, with alisertib (MLN8237), an Aurora A kinase inhibitor, for cancer therapy

by Collins, Sabrina, Blair, Derek, Zarycki, Jodi, Szynal, Carmin, Gangolli, Esha, Vincent, Patrick, Chakravarty, Arijit, Ecsedy, Jeffrey
Published in Cancer research (Chicago, Ill.) (15.04.2012)

Get full text

Journal Article

Abstract B136: Application of a mathematical model to understand the cell cycle progression effects of MEK1/2 kinase inhibition using the investigational small-molecule allosteric inhibitor TAK-733

Abstract B136: Application of a mathematical model to understand the cell cycle progression effects of MEK1/2 kinase inhibition using the investigational small-molecule allosteric inhibitor TAK-733

by Blair, Derek, Mettetal, Jay, Collins, Sabrina, Zarycki, Jodi, Vincent, Patrick, Ecsedy, Jeffrey, Chakravarty, Arijit
Published in Molecular cancer therapeutics (12.11.2011)

Get full text

Journal Article

Promoting positive mental health and reducing anxiety : lessons for living : think well, do well

Promoting positive mental health and reducing anxiety : lessons for living : think well, do well

by Collins, Sabrina
Year of Publication 2011

Get full text

Dissertation